Article Text
Abstract
Informed consent to medical intervention reflects the moral principle of respect for autonomy and the patient's right to self-determination. In psychotherapy, this includes a requirement to inform the patient about those components of treatment purported to cause the therapeutic effect. This information must encompass positive expectancies of change and placebo-related or incidental constituent therapy effects, which are as important as specific intervention techniques for the efficacy of psychotherapy. There is a risk that informing the patient about possible incidental constituents of therapy may reduce or even completely impede these effects, with negative consequences for overall outcome. However, withholding information about incidental constituents of psychotherapy would effectively represent a paternalistic action at the expense of patient autonomy; whether such paternalism might in certain circumstances be justified forms part of the present discussion.
- Autonomy
- Informed Consent
- Psychiatry
- Psychotherapy
- Mentally Ill and Disabled Persons
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Informed consent in neurosurgery—translating ethical theory into action
- Psychotherapy, placebos, and informed consent
- Medical ethics for children: applying the four principles to paediatrics
- Treating competent patients by force: the limits and lessons of Israel’s Patient’s Rights Act
- Talking more about talking cures: cognitive behavioural therapy and informed consent
- Towards evidence based bioethics
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection
- Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial
- Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
- Replication crisis and placebo studies: rebooting the bioethical debate